Stay updated on CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial

Sign up to get notified when there's something new on the CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Updated to Revision: v3.0.2 (from v3.0.1); the 'Back to Top' element was removed.
    Difference
    0.8%
    Check dated 2025-09-13T16:58:55.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.8%
    Check dated 2025-09-06T14:30:56.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while several location-related terms have been removed.
    Difference
    10%
    Check dated 2025-08-30T11:23:00.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T04:32:05.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.3%
    Check dated 2025-08-08T23:48:33.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    4%
    Check dated 2025-08-01T19:15:29.000Z thumbnail image

Stay in the know with updates to CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial page.